title: [Treatment of the acute diverticulitis: A systematic review].
abstract: Acute diverticulitis is a common disease with increasing incidence. In most of cases, diagnosis is made at an uncomplicated stage offering a curative attempt under medical treatment and use of antibiotics. There is a risk of diverticulitis recurrence. Uncomplicated diverticulitis is opposed to complicated forms (perforation, abscess or fistula). Recent insights in the pathophysiology of diverticulitis, the natural history, and treatments have permitted to identify new treatment strategies. For example, the use of antibiotics tends to decrease; surgery is now less invasive, percutaneous drainage is preferred, peritoneal lavage is encouraged. Treatments of the diverticulitis are constantly evolving. In this review, we remind the pathophysiology and natural history, and summarize new recommendations for the medical and surgical treatment of acute diverticulitis.
authors.affiliation: AP-HP, université Paris Descartes, faculté de médecine, hôpital Cochin, gastroenterology and endoscopy unit, Sorbonne Paris Cité, 75014 Paris, France. Electronic address: johann.dreanic@cch.aphp.fr.
authors.forename: Johann
authors.initials: J
authors.lastname: Dréanic
authors.affiliation: AP-HP, université Paris Descartes, faculté de médecine, hôpital Cochin, gastroenterology and endoscopy unit, Sorbonne Paris Cité, 75014 Paris, France.
authors.forename: Elena
authors.initials: E
authors.lastname: Sion
authors.affiliation: AP-HP, université Paris Descartes, faculté de médecine, hôpital Cochin, gastroenterology and endoscopy unit, Sorbonne Paris Cité, 75014 Paris, France.
authors.forename: Marion
authors.initials: M
authors.lastname: Dhooge
authors.affiliation: AP-HP, université Paris Descartes, faculté de médecine, hôpital Cochin, digestive surgery, Sorbonne Paris Cité, 75014 Paris, France.
authors.forename: Bertrand
authors.initials: B
authors.lastname: Dousset
authors.affiliation: AP-HP, université Paris Descartes, faculté de médecine, hôpital Cochin, gastroenterology and endoscopy unit, Sorbonne Paris Cité, 75014 Paris, France.
authors.forename: Marine
authors.initials: M
authors.lastname: Camus
authors.affiliation: AP-HP, université Paris Descartes, faculté de médecine, hôpital Cochin, gastroenterology and endoscopy unit, Sorbonne Paris Cité, 75014 Paris, France.
authors.forename: Stanislas
authors.initials: S
authors.lastname: Chaussade
authors.affiliation: AP-HP, université Paris Descartes, faculté de médecine, hôpital Cochin, gastroenterology and endoscopy unit, Sorbonne Paris Cité, 75014 Paris, France.
authors.forename: Romain
authors.initials: R
authors.lastname: Coriat
mesh_terms: D000038:Abscess / Q000209:etiology / Q000601:surgery; D000208:Acute Disease; D000367:Age Factors; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D015897:Comorbidity; D004043:Dietary Fiber / Q000627:therapeutic use; D019468:Disease Management; D018450:Disease Progression; D004238:Diverticulitis / Q000150:complications / Q000453:epidemiology / Q000503:physiopathology / Q000628:therapy*; D004322:Drainage / Q000379:methods; D017558:Elective Surgical Procedures; D006760:Hospitalization; D006801:Humans; D007416:Intestinal Perforation / Q000209:etiology; D010535:Laparoscopy; D015337:Multicenter Studies as Topic; D010538:Peritonitis / Q000209:etiology; D019936:Probiotics / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence; D012294:Rifamycins / Q000627:therapeutic use; D000078262:Rifaximin; D007507:Therapeutic Irrigation
chemical_list: D000900:Anti-Bacterial Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D004043:Dietary Fiber; D012294:Rifamycins; D000078262:Rifaximin